Results 241 to 250 of about 96,828 (293)

CT-derived Body Composition Radiomics to Predict Early Recurrence in Intrahepatic Cholangiocarcinoma. [PDF]

Radiol Imaging Cancer
Singh Y.
europepmc   +1 more source

Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors. [PDF]

Clin Cancer Res
Facchinetti F, Hollebecque A, Barbé R, Jang DM, Alonso-De-Castro B, Brayé F, Bigot L, Nobre C, Da Silva A, Méteau M, Delavigne M, Soares M, Italiano A, Rodriguez J, Mosele F, Beshiri K, Ducreux M, Boilève A, Nikolaev S, Alonso-Garcia I, Vasseur D, Smolenschi C, Bourien H, Cotteret S, Samaniego J, Bernard E, Nicotra C, Ngo-Camus M, Nakazawa S, Tselikas L, Badoual C, André F, Eck MJ, Olaussen KA, Loriot Y, Friboulet L.   +35 more
europepmc   +1 more source

Integrative single-cell and machine-learning analysis identifies ac⁴C-related S100A13 as a causal risk gene in cholangiocarcinoma. [PDF]

BMC Cancer
Zheng Y, Lin Y, Wang Z, Wu F.
europepmc   +1 more source

v. 83, issue 2, October 1, 2015 [PDF]

, 2015

core   +1 more source

Ivosidenib for cholangiocarcinoma and acute myeloid leukaemia. [PDF]

Aust Prescr
europepmc   +1 more source

Imaging differentiation of hepatocellular carcinoma, combined hepatocellular-cholangiocarcinoma, and intrahepatic cholangiocarcinoma: pitfalls and advances. [PDF]

J Liver Cancer
Shin J, Chung T, Ha SY, Rhee H.
europepmc   +1 more source

TREM2 inhibits cholangiocarcinoma progression by regulating the TGF-β/Smad2/3 signaling pathway. [PDF]

Am J Cancer Res
Lei X, Hao J, Gou Y, Huang X.
europepmc   +1 more source